Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 1
2010 1
2011 1
2012 4
2013 3
2014 5
2015 4
2016 3
2017 4
2018 7
2019 1
2020 2
2021 2
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Fenretinide in young women at genetic or familial risk of breast cancer: A placebo-controlled biomarker trial.
Aristarco V, Serrano D, Maisonneuve P, Guerrieri-Gonzaga A, Lazzeroni M, Feroce I, Macis D, Cavadini E, Albertazzi E, Jemos C, Omodeo Salè E, Cortesi L, Massarut S, Gulisano M, Daidone MG, Johansson H, Bonanni B. Aristarco V, et al. Among authors: feroce i. Cancer Prev Res (Phila). 2024 Mar 26. doi: 10.1158/1940-6207.CAPR-23-0422. Online ahead of print. Cancer Prev Res (Phila). 2024. PMID: 38530139
Germline pathogenic variants in metaplastic breast cancer patients and the emerging role of the BRCA1 gene.
Corso G, Marabelli M, Calvello M, Gandini S, Risti M, Feroce I, Mannucci S, Girardi A, De Scalzi AM, Magnoni F, Marino E, Bernard L, Veronesi P, Guerini-Rocco E, Barberis M, Guerrieri-Gonzaga A, Bonanni B. Corso G, et al. Among authors: feroce i. Eur J Hum Genet. 2023 Nov;31(11):1275-1282. doi: 10.1038/s41431-023-01429-2. Epub 2023 Jul 18. Eur J Hum Genet. 2023. PMID: 37460658
Metaplastic breast cancer: an all-round multidisciplinary consensus.
Corso G, Criscitiello C, Nicosia L, Pesapane F, Vicini E, Magnoni F, Sibilio A, Zanzottera C, De Scalzi AM, Mannucci S, Marabelli M, Calvello M, Feroce I, Zagami P, Porta FM, Toesca A, Tarantino P, Nicolò E, Mazzarol G, La Vecchia C, Bonanni B, Leonardi MC, Veronesi P, Fusco N. Corso G, et al. Among authors: feroce i. Eur J Cancer Prev. 2023 Jul 1;32(4):348-363. doi: 10.1097/CEJ.0000000000000794. Epub 2023 May 12. Eur J Cancer Prev. 2023. PMID: 37021548
A randomized controlled trial comparing self-referred message to family-referred message promoting men's adherence to evidence-based guidelines on BRCA1/2 germline genetic testing: A registered study protocol.
Petrocchi S, Ongaro G, Calvello M, Feroce I, Bonanni B, Pravettoni G. Petrocchi S, et al. Among authors: feroce i. PLoS One. 2022 Apr 8;17(4):e0266327. doi: 10.1371/journal.pone.0266327. eCollection 2022. PLoS One. 2022. PMID: 35395021 Free PMC article.
Is tumor testing efficiency for Lynch syndrome different in rectal and colon cancer?
Marabelli M, Gandini S, Rafaniello PR, Calvello M, Tolva G, Feroce I, Lazzeroni M, Marino E, Dal Molin M, Trovato C, Guerrieri-Gonzaga A, Petz WL, Barberis M, Bertario L, Bonanni B. Marabelli M, et al. Among authors: feroce i. Dig Liver Dis. 2020 Dec;52(12):1503-1511. doi: 10.1016/j.dld.2020.06.002. Epub 2020 Jun 30. Dig Liver Dis. 2020. PMID: 32620519
40 results